EndoC-βH1 — PKBSM2973NJDC
Summary
EndoC-βH1 cell line, depleted of NLRC5 for 8 hours, treated with 2000 U/mL Interferon alpha for 8 hours
Sample Terms
Sources
Sample Name
EndoC-bH1
Classifications
human beta cell line
Growth Medium
Dulbecco’s modified Eagle medium with 5.6 mM glucose, 2% fatty acid–free BSA fraction V, 50 μM 2-mercaptoethanol, 10 mM nicotinamide, transferrin, selenite (6.7 ng/ml), and penicillin (100 U/ml) + streptomycin (100 μg/ml)
Nucleic Acid Delivery
Lipofectamine RNAiMAX
Age
unknown
Coating Condition
Matrigel-fibronectin
Taxa
Homo sapiens
Description
EndoC-bH1 cells treated with NLRC5 siRNA and IFNa for 8hr from GSE202852
Publication Identifiers
File SetsReport view
2 items
Treatments
2 items
Summary
stimulation
protein
Treatment of 2000 U/mL Interferon alpha for 8 hours
perturbation
protein
Depletion of NLRC5 for 8 hours
Attribution
Funding
Supported by National Institutes of Health (NIH) grants U24 DK138515, U24 DK138512
Supplemental funds from the NIH Office of Data Science Strategies
Supplemental funds from the NIH Office of Data Science Strategies
